DNMT3A c.2552dup ;(p.M852Hfs*3)

Variant ID: 2-25458620-G-GA

NM_022552.4(DNMT3A):c.2552dup;(p.M852Hfs*3)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.

Plos One
Valori, Miko M; Jansson, Lilja L; Tienari, Pentti J PJ
Publication Date: 2021

Variant appearance in text: DNMT3A: 2552dupT
PubMed Link: 34874980
Variant Present in the following documents:
  • pone.0261002.s008.xlsx, sheet 1
View BVdb publication page



CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.

Plos One
Valori, Miko M; Jansson, Lilja L; Tienari, Pentti J PJ
Publication Date: 2021

Variant appearance in text: DNMT3A: 2552dupT
PubMed Link: 34874980
Variant Present in the following documents:
  • pone.0261002.s008.xlsx, sheet 1
View BVdb publication page



Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.

Leukemia
Dawoud, Ahmed A Z AAZ; Gilbert, Rodney D RD; Tapper, William J WJ; Cross, Nicholas C P NCP
Publication Date: 2022-02

Variant appearance in text: DNMT3A: 2552dupT; M852Hfs*3
PubMed Link: 34413458
Variant Present in the following documents:
  • 41375_2021_1382_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page